Predict your next investment

Angel Investor (Individual)

See what CB Insights has to offer

Investments

6

About Jim Breyer

Jim Breyer Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Jim Breyer News

Venture capitalist Jim Breyer says Twitter intrinsic value $25 to $30/share

May 25, 2022

Scott Olson/Getty Images News Jim Breyer, a noted venture capital and CEO of namesake Breyer Capital said he believes Twitter's (NYSE: TWTR ) intrinsic value is $25 to $30/share. Elon Musk "is paying too much for Twitter," Breyer said earlier in an interview with CNBC from Davos, Switzerland. "I think the fair value of Twitter, in my humble opinion, is $25 to to $30." Breyer's comments come as some believe Musk's recent battle with Twitter over the deal may be an effort by the billionaire Tesla ( TSLA ) CEO to get a price cut for the transaction. Twitter told employees last week it wouldn't renegotiate the agreed price of $54.20/share. Twitter jumped 9.4% in postmarket trading on Wednesday after a new amended ownership filing from Elon Musk, stating that he's raised his aggregate equity commitment for a proposed $44 billion takeover of the company. Breyer also said in the interview that stocks he's recent recently purchased include Blackstone ( BX ), where he's a board member, Microsoft ( MSFT ), Apple ( AAPL ) and Alphabet ( GOOGL ). Earlier Wednesday, Twitter held its annual meeting with no Musk details, but some board surprises. To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Jim Breyer Investments

6 Investments

Jim Breyer has made 6 investments. Their latest investment was in TympaHealth as part of their Seed VC on February 2, 2022.

CBI Logo

Jim Breyer Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/17/2022

Seed VC

TympaHealth

$8M

Yes

8

12/6/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

1/12/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

4/10/2020

Series C

Subscribe to see more

$99M

Subscribe to see more

10

11/1/2018

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/17/2022

12/6/2021

1/12/2021

4/10/2020

11/1/2018

Round

Seed VC

Series B

Series A

Series C

Series A

Company

TympaHealth

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$8M

$99M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

8

10

10

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.